• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Lux Health Tech Acquisition Corp. (Amendment)

    2/14/22 10:08:51 AM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials
    Get the next $LUXA alert in real time by email
    SC 13G/A 1 p22-0492sc13ga.htm LUX HEALTH TECH ACQUISITION CORP.

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
     
    SCHEDULE 13G/A
     
    Under the Securities Exchange Act of 1934
    (Amendment No. 1 )*
     

    Lux Health Tech Acquisition Corp.

    (Name of Issuer)
     

    Class A Common Stock, $0.0001 par value

    (Title of Class of Securities)
     

    55068A100

    (CUSIP Number)
     

    December 31, 2021

    (Date of Event Which Requires Filing of this Statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    x Rule 13d-1(b)
    ¨ Rule 13d-1(c)
    ¨ Rule 13d-1(d)
     
    (Page 1 of 7 Pages)

     

    ______________________________

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     CUSIP No. 55068A10013G/APage 2 of 7 Pages

     

    1

    NAME OF REPORTING PERSON

     

    D1 Capital Partners L.P.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    0

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    0

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    0%

    12

    TYPE OF REPORTING PERSON

    PN, IA

             

     

     

     CUSIP No. 55068A10013G/APage 3 of 7 Pages

     

     

    1

    NAME OF REPORTING PERSON

     

    Daniel Sundheim

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United States of America

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    0

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    0

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    0%

    12

    TYPE OF REPORTING PERSON

    IN, HC

             

     

     

     CUSIP No. 55068A10013G/APage 4 of 7 Pages

     

     

    Item 1(a). Name of Issuer.
       
      Lux Health Tech Acquisition Corp. (the “Issuer”)

     

    Item 1(b). Address of Issuer’s Principal Executive Offices.
       
     

    920 Broadway, 11th Floor

    New York, NY 10010

     

    Item 2(a). Name of Person Filing.
       
      This statement is filed by D1 Capital Partners L.P. (the “Investment Manager”) and Daniel Sundheim (“Mr. Sundheim”). The foregoing persons are hereinafter sometimes referred to as the “Reporting Persons.”
       
      The Investment Manager is a registered investment adviser and serves as the investment manager of private investment vehicles and accounts, including D1 Capital Partners Master LP (the "Investment Vehicle"), and may be deemed to beneficially own the shares of Class A Common Stock held by the Investment Vehicle and/or its subsidiary. Mr. Sundheim indirectly controls the Investment Manager and may be deemed to beneficially own the shares of Class A Common Stock held by the Investment Vehicle and/or its subsidiary.
       
      The filing of this statement should not be construed as an admission that any Reporting Person is, for the purposes of Section 13 of the Securities Exchange Act of 1934, as amended, the beneficial owner of the securities reported herein.
       
    Item 2(b). Address of Principal Business Office.
       
     

    D1 Capital Partners L.P.

    9 West 57th Street, 36th Floor

    New York, New York 10019

     

    Daniel Sundheim

    c/o D1 Capital Partners L.P.

    9 West 57th Street, 36th Floor

    New York, New York 10019

       
    Item 2(c). Place of Organization.
       
     

    Investment Manager – Delaware

    Mr. Sundheim – United States of America

     

    Item 2(d). Title of Class of Securities.
       
      Class A common stock, $0.0001 par value (the “Class A Common Stock”)

     

     CUSIP No. 55068A10013G/APage 5 of 7 Pages

     

     

    Item 2(e). CUSIP Number.
       
      55068A100

     

    Item 3. If this Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the Person Filing is a:

     

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
      (e) x An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
      (f) ¨

    An employee benefit plan or endowment fund in accordance with
    § 240.13d-1(b)(1)(ii)(F);

     

      (g) x

    A parent holding company or control person in accordance with
    § 240.13d-1(b)(1)(ii)(G);

     

      (h) ¨

    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);

     

      (i) ¨

    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

     

      (j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(K).

     

     

    If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please

    specify the type of institution:________________________________

     

    Item 4. Ownership.
       
      The information required by Items 4(a) – (c)  is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

     

     CUSIP No. 55068A10013G/APage 6 of 7 Pages

     

     

    Item 5. Ownership of Five Percent or Less of a Class.
       
      If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:  x

     

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
       
      Not applicable.

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
       
      Not applicable.

     

    Item 8. Identification and Classification of Members of the Group.
       
      Not applicable.

     

    Item 9. Notice of Dissolution of Group.
       
      Not applicable.

     

    Item 10. Certification.
       
     

    By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

     CUSIP No. 55068A10013G/APage 7 of 7 Pages

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Date:  February 14, 2022  
      D1 Capital Partners L.P.
       
      By:  /s/ Amanda Hector
      Name:  Amanda Hector
      Title:    General Counsel and Chief Compliance Officer
       
       
       
      /s/ Daniel Sundheim
      DANIEL SUNDHEIM

     

     

     

    Get the next $LUXA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LUXA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LUXA
    SEC Filings

    View All

    SEC Form 15-12G filed by Lux Health Tech Acquisition Corp.

    15-12G - Lux Health Tech Acquisition Corp. (0001823767) (Filer)

    11/8/22 4:05:16 PM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials

    SEC Form 25-NSE filed by Lux Health Tech Acquisition Corp.

    25-NSE - Lux Health Tech Acquisition Corp. (0001823767) (Subject)

    10/28/22 4:24:39 PM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials

    Lux Health Tech Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Lux Health Tech Acquisition Corp. (0001823767) (Filer)

    10/7/22 4:29:45 PM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials

    $LUXA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lux Health Tech Acquisition Corp. Announces Cancellation of Special Meeting of Stockholders and Liquidation

    Lux Health Tech Acquisition Corp. (the "Company") today announced that it has cancelled its special meeting of stockholders that was previously scheduled for 9:00 AM Pacific time on October 13, 2022, and that, because the Company will not consummate an initial business combination within the time period required by its Second Amended and Restated Certificate of Incorporation, the Company intends to dissolve and liquidate, effective as of the close of business on October 29, 2022, and will redeem all of the outstanding shares of Class A common stock that were included in the units issued in its initial public offering (the "Public Shares"), at a per-share redemption price of approximately $1

    10/7/22 4:15:00 PM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials

    Lux Health Tech Acquisition Corp. Signs Letter of Intent for a Business Combination

    Lux Health Tech Acquisition Corp. (the "Company") today announced that it has entered into a non-binding letter of intent ("LOI") for a business combination with a leading life sciences company addressing significant unmet needs in some of the most costly and debilitating segments of healthcare (the "Target"). The Target has an experienced executive and scientific leadership team that has built an extensive technology platform with multiple programs in development, and is backed by leading private and public market investors. The Company expects that it can offer the Target its resources, experience and network of relationships to support the Target's growth and access to public markets, m

    9/6/22 8:10:00 AM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials

    $LUXA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Lux Health Tech Acquisition Corp. (Amendment)

    SC 13G/A - Lux Health Tech Acquisition Corp. (0001823767) (Subject)

    1/19/23 7:23:30 AM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G/A filed by Lux Health Tech Acquisition Corp. (Amendment)

    SC 13G/A - Lux Health Tech Acquisition Corp. (0001823767) (Subject)

    2/14/22 10:08:51 AM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G filed by Lux Health Tech Acquisition Corp.

    SC 13G - Lux Health Tech Acquisition Corp. (0001823767) (Subject)

    2/11/22 12:22:40 PM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials